The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A Meta-Analysis of Randomized Trials Evaluating Ondansetron (O), Granisetron (G) and Tropisetron (T).
 
Peter Zang
No Relationships to Disclose
 
Alexandra Drakaki
No Relationships to Disclose
 
Izak Faiena
No Relationships to Disclose
 
Betty Chan
No Relationships to Disclose
 
Denice Tsao-Wei
No Relationships to Disclose
 
Susan G. Groshen
No Relationships to Disclose
 
David I. Quinn
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; EMD Serono; Exelixis; Genentech/Roche; Merck Serono; Merck Sharp & Dohme; Peloton Therapeutics; Pfizer; Piramal Life Science; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; EMD Serono; Exelixis; Genentech/Roche; Merck Serono; Merck Sharp & Dohme; Peloton Therapeutics; Pfizer; Piramal Life Science; Sanofi
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Millennium (Inst); Sanofi (Inst)
 
Tanya B. Dorff
Honoraria - Astellas Pharma; Dendreon; Exelixis; Medivation; Pfizer
Consulting or Advisory Role - Bayer; Dendreon; Eisai; EMD Serono; Genentech
Speakers' Bureau - Astellas Pharma; Dendreon; Exelixis; Pfizer
Research Funding - Bristol-Myers Squibb